# Trial of DFP-14927 in Advanced Solid Tumors

> **NCT03943004** · PHASE1 · RECRUITING · sponsor: **Delta-Fly Pharma, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Solid Tumor
- Cancer

## Interventions

- **DRUG:** DFP-14927

## Key facts

- **NCT ID:** NCT03943004
- **Lead sponsor:** Delta-Fly Pharma, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2019-09-30
- **Primary completion:** 2026-03-01
- **Final completion:** 2026-06-01
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-03-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03943004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03943004, "Trial of DFP-14927 in Advanced Solid Tumors". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT03943004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*